You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股醫藥股普漲 石藥集團(1093.HK)漲近4%
格隆匯 10-14 11:58
格隆匯10月14日丨港股醫藥股普漲,其中,石藥集團、東陽光藥、三生製藥、白雲山、遠大醫藥、綠葉製藥漲幅均在3%以上。整體來看,三季報業績漸進,醫藥行業三季報值得關注。
就石藥集團來看,目前集團的CSPCHA115膠囊正在進行1期臨牀;此外,在近日舉行的2019中國醫藥企業家科學家投資家大會暨新中國成立70週年醫藥產業發展成就展上,石藥集團四項榮譽同時加冕:在2019中國醫藥上市公司競爭力20強榜單、中國醫藥創新企業100強榜單中,石藥集團均躋身前三甲,並上榜2019中國最具投資價值醫藥上市公司10強榜單,位列第4名。在一併發佈的新中國成立70週年醫藥產業優秀企業光榮榜中,石藥集團榮獲“脊樑企業”稱號。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account